AlphaHelix Molecular Diagnostics is active within medical technology. Today the business is focused on development of patented technology enabling the identification of viruses and bacteria. Products are sold under a number of trademarks as well as through own distribution to laboratories and research institutes. The largest business is found within the Nordic market. The head office is located in Nacka.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Labkompaniet i Sverige AB | 31,35 | 31,35 | 2024-03-26 |
| Nordnet Pensionsförsäkring | 7,56 | 7,56 | 2024-03-26 |
| Avanza Pension | 5,82 | 5,82 | 2024-03-26 |
| Active Healthtech Nordic AB | 5,49 | 5,49 | 2024-03-26 |
| Tobias Schön | 5,14 | 5,14 | 2023-12-31 |
| Jörgen Henriksen | 3,82 | 3,82 | 2024-03-26 |
| Bengt Koltman | 3,79 | 3,79 | 2024-03-26 |
| TTA-LG HoldCo AB | 3,02 | 3,02 | 2024-03-26 |
| Anders Reisch | 2,30 | 2,30 | 2024-03-26 |
| Ole Ardahl Sörensen | 1,93 | 1,93 | 2024-03-26 |
2024-04-25 Delårsrapport 2024-Q1
